{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:42:55Z","timestamp":1770500575762,"version":"3.49.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jocn.2025.111683","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:17:21Z","timestamp":1761092241000},"page":"111683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The nosology of tardive parkinsonism"],"prefix":"10.1016","volume":"142","author":[{"given":"Stefano","family":"Calzetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1391-9510","authenticated-orcid":false,"given":"Giacomo","family":"Calzetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2025.111683_b0005","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, DSM-V TR, American Psychiatric Publishing, Washington DC, USA, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.jocn.2025.111683_b0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jns.2018.02.008","article-title":"The nosology of tardive syndromes","volume":"389","author":"Frei","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2025.111683_b0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/jnnp-2017-315873","article-title":"Early onset drug-induced parkinsonism after exposure to offenders implies nigro-sriatal dopaminergic dysfunction","volume":"89","author":"Chung","year":"2018","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"10.1016\/j.jocn.2025.111683_b0020","article-title":"Outcome of Drug-Induced Parkinsonism in the elderly: a Permanent Nonprogressive Parkinsonian Syndrome May Occur following Discontinuation of Cinnarizine and Flunarizine","volume":"1\u20135","author":"Calzetti","year":"2024","journal-title":"Ann Pharmacother"},{"issue":"7","key":"10.1016\/j.jocn.2025.111683_b0025","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/mds.28046","article-title":"Chronic Neuroleptic-Induced Parkinsonism Examined with Positron Emission Tomography","volume":"35","author":"Galoppin","year":"2020","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.jocn.2025.111683_b0030","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/mds.23828","article-title":"Drug Induced Parkinsonism: a Review of 17 Years\u2019 Experience in a Regional Pharmacovigilance Center in France","volume":"26","author":"Bondon-Guitton","year":"2011","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.jocn.2025.111683_b0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/mds.870120119","article-title":"A Long-Term Follow-up Study of Cinnarizine- and Flunarizine-Induced Parkinsonism","volume":"12","author":"Negrotti","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2025.111683_b0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1353-8020(98)00032-7","article-title":"Calcium channel blocker- induced Parkinsonism: clinical features and comparison with Parkinson\u2019s disease","volume":"4","author":"Garc\u00eda-Ruiz","year":"1998","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jocn.2025.111683_b0045","article-title":"Tardive Syndromes are Rarely Reversible after Discontinuing Dopamine Receptor Blocking Agents: Experience from a University-based Movement Disorder Clinic","volume":"4","author":"Zutshi","year":"2014","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"10.1016\/j.jocn.2025.111683_b0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3988\/jcn.2012.8.1.15","article-title":"Drug-Induced Parkinsonism","author":"Shin","year":"2012","journal-title":"J Clin Neurol"},{"issue":"3","key":"10.1016\/j.jocn.2025.111683_b0055","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1148\/radiol.2015151466","article-title":"Drug-induced parkinsonism versus idiopathic Parkinson disease: utility of nigrosome 1 with 3T imaging","volume":"279","author":"Sung","year":"2016","journal-title":"Radiology"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825006563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825006563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T16:39:46Z","timestamp":1770309586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586825006563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":11,"alternative-id":["S0967586825006563"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111683","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The nosology of tardive parkinsonism","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111683"}}